The distribution of the ratios of plasma high-density lipoprotein cholesterol (HDL-C) to total cholesterol (TC) and of HDL-C to low-density lipoprotein cholesterol (LDL-C) are presented for 6900 white and 495 black examinees greater than 4 years old. Measurements were obtained during the visit 2 survey of the Lipid Research Clinics (LRC) Program Prevalence Study, and correspond to a 15% random sample of 60,502 participants screened during the LRC visit 1 survey. Age-specific means, medians, and selected percentiles are given by sex and by gonadal hormone use in white women. Apparent in these cross-sectional data was a consistent age-related decline in the ratio of HDL-C to TC for white male participants, from a mean of 0.360 in the age group 5 to 9 to a mean of 0.21 1 in the age group 50 to 54. Thereafter the mean ratio increased slightly. In white women not using gonadal hormones the age-related decline in the ratio was only evident starting at the age group 35 to 39, from which it declines from 0.329 to 0.258 in the age group 55 to 59. White women using gonadal hormones showed very minor age-related changes in the HDL-C/TC ratio, varying around a mean of 0.300. The number of blacks examined was low and thus the racial comparisons must be interpreted with caution. For each gender, age-related trends were similar in black and white study participants. Black men, however, had a higher percentage of TC carried as HDL-C than white men in all age groups examined. Black women had a higher percentage of TC in HDL-C than white women only below age 20; in the adult age range no appreciable differences were seen. Pearson correlation coefficients between the lipid, lipoprotein, and lipoprotein ratios are presented. The ratio HDL-C/TC correlated highly with the ratio HDL-C/LDL-C (greater than 0.92 for all groups) and the former may be a more conveniently determined surrogate for the latter. Although not exhaustive regarding the information it conveys about a lipid pattern, the ratio HDL-C/TC has the advantage of summarizing complex associations into a single numerical approximatiorn. ischemic heart disease (IHD). This association has been described as being the result largely of the atherogenic effect of the cholesterol carried in the low-density lipoprotein (LDL). 1 In 195 1, Barr et al.' reported the results of a case-control study in which it was found that patients with IHD had lower blood concentrations of high-density lipoprotein (HDL) than healthy control subjects. This initial suggestion that the blood concentrations of the lipoprotein cholesterol fractions may be more sensitive predictors of IHD risk than the TC concentration was confirmed in 1966 when Gofman et al.3 published the results of a cohort study with a 10 year follow-up in which lower plasma HDL cholesterol (HDL-C) levels were demonstrated among men who subsequently developed IHD.
SINCE the late 1940s considerable epidemiologic evidence has accumulated in support of a strong association between elevated blood concentrations of total cholesterol (TC) and the subsequent development of of the various reported case-control and cohort studies designed to evaluate the association between blood concentration of HDL-C and IHD. The studies have been remarkably consistent in finding reduced blood HDL-C levels associated with increased IHD risk, and several investigators have found that the plasma concentration of HDL-C is a superior predictor of IHD risk compared with the blood TC concentration. 6 Nonetheless it is clear that the use of blood HDL-C concentrations as the sole lipid parameter in assessing IHD risk excludes other potentially valuable information. The low-density lipoprotein cholesterol (LDL-C) concentration in the blood, which is highly correlated with the TC concentration, has also been found in most epidemiologic studies to be strongly and positively associated with IHD risk. Furthermore, whereas the association between blood HDL-C concentration and IHD risk has been studied relatively recently, there is long-standing evidence of increased IHD risk with increasing blood TC levels, and this phenomenon has been demonstrated both within and between populations. 8 The experimental evidence on the association between blood lipoprotein cholesterol fractions and atherosclerotic disease is also substantial. Atherosclerosis can be induced in laboratory animals by significantly increasing the serum TC.9 11) The Lipid Research Clinics (LRC) Coronary Primary Prevention Trial findings demonstrate that a plasma TC reduction achieved by lowering LDL-C can reduce the incidence of IHD morbidity and mortality in men with high LDL-C levels." Also, an inverse relationship was found in the NHLBI Type II Coronary Intervention Study between coronary artery disease (CAD) progression and the combination of an increase in HDL-C and a decrease in LDL-C. The best predictors of changes indicative of CAD were changes in the ratios HDL-C/TC and HDL-C/LDL-C. ' Thus, both epidemiologic and experimental evidence tend to suggest that an index that combines the blood concentrations of HDL-C and LDL-C may adequately represent the joint contribution of the lipoproteins to IHD risk. A simple index that reflects the relative concentrations of HDL-C to LDL-C is the ratio of HDL-C to LDL-C (or the inverse). In practice, since TC is more easily measured than LDL-C and since the two are very highly correlated with one another,7 the ratio of HDL-C to TC may be a more convenient index than the ratio of HDL-C to LDL-C, and may contain essentially the same information.
While there is clearly a need for more analytic evidence to substantiate the use of these ratios in IHD risk profiles, at this stage it is believed that descriptive data on these ratios in free-living populations would be useful to researchers, to clinicians, and to public health workers. The prevalence studies of the LRC program provide a unique data base for this purpose; studies were conducted as population surveys performed by a common protocol and rigorously standardized laboratories. In this communication we present a description of the distributions of the ratios of HDL-C to LDL-C and TC, and their association with sex, age, and sex hormone use by women, in the 10 North American populations studied by the LRC program. It is the aim of this report to provide a reference guide for use in the clinical context and as a basis for comparison with other populations.
Methods
The population studies component of the LRC program has been described in detail elsewhere.'3 14 Briefly, 10 LRCs in the United States and Canada completed a series of population surveys between 1971 and 1976. The LRCs selected their study populations to ensure wide ethnic, geographic, socioeconomic, and age variation; the collaborative LRC data are not, however, representative of the Canadian or U.S. populations. All clinics used a common protocol' and highly standardized methods. ' 5 A total of 13,852 participants of both sexes were examined during the LRC visit 2 survey. Of these, 7733 constitute a 15% randomly sampled subset of LRC visit I participants. Data presented in this report are from 3535 white male, 3365 white female, 228 black male, and 267 black female participants who were part of the random sample at visit 2. Criteria for exclusion from the analyses were fasting less than 12 hr before blood sampling, missing data for HDL-C TC (for the analyses on HDL-C/TC). or LDL-C (for the analyses on HDL-C/LDL-C), pregnancy, or age less than 5 years. These criteria excluded a total of 153 observations. Also, two grossly unusual LDL-C values were regarded as missing values. The number of black women reporting the use of gonadal hormones was insufficient for the descriptive analyses presented in this report. The data from these 25 women are not presented here but are available on request.
The sampling frames and number of study participants for the LRCs have been reported elsewhere.'13 Overall participation rates were 74% for visit 1 and 85% for visit 2. The data are presented as arithmetic means and SDs. In addition, where the sample sizes were adequate several percentiles are provided. For small sample sizes only the median is given. Correlation coefficients were only computed for the variables measured in the white participants. and since the sample sizes were large, Pearson correlation coefficients were considered adequate despite the skewed distributions of some of the variables.
Laboratory methods. A detailed description of the laborators processing procedures is provided in the LRC Laboratory Methods Manual.' 5Briefly, plasma cholesterol and triglyceride levels were determined in each LRC core laboratory by use of Technicon Autoanalyzer I (AA-I) or Autoanalyzer II (AA-11), adapted by the LRC program. On frozen serum pools the AA-I instruments produced cholesterol values 2. 1% higher than the manual Abell-Kendell target values. the AA-II instruments gave values .3% lower than target values. 16 For plasma triglyceride concentrations the individual instrument biases varied from 4.9% below to 1.0% above reference values. Between-run variability was often less than within-run variabilty and interlaboratory variation was considerably less than intralaboratory variation.'6 All study determinations were done on fresh samples and the comparative data indicate instrument differences even less than the values ascertained for frozen samples.6'-8 Lipoproteins were separated by ultracentrifugal flotation at saline density (d = 1.006 g/ml) to yield a supernatant fraction containing very low-density lipoprotein cholesterol (VLDL-C) and an infranatant fraction containing both LDL-C and HDL-C.
HDL-C was estimated in total plasma after precipitation of the apo B-containing lipoproteins by means of heparin-manganese chloride. After direct estimation of HDL-C, LDL-C was computed by subtracting the HDL-C from the cholesterol in the 1.006 infranatant. Concentrations of VLDL-C were determined by subtracting the cholesterol in the 1.006 infranatant from the TC. In instances of incomplete precipitation of VLDL-C and LDL-C, the procedure was repeated on the infranatant fraction after ultracentrifugation.19
To ensure interlaboratory comparability of ultracentrifugal results on lipoproteins, 53 "freshly" collected frozen plasma pools were distributed quarterly, over a 31/2 year period, to each laboratory. The average coefficients of interclinic variability in lipoprotein-cholesterol analyses in these samples were 5% for LDL-C and 10% to 15% for HDL-C.20
Results
The distributions of plasma lipids and lipoprotein cholesterol fractions in the LRC participants examined by the North American LRCs have been published elsewhere. 13. [20] [21] [22] The distributions of the ratio of HDL-C to TC by age, sex, and hormone use for the white participants in the LRC visit 2 random sample are shown in tables 1 to 3. The means, medians, and 10th TABLE 1 Mean and percentile values for the ratio of plasma HDL-C to TC by age in white male participants, 5 Fifth and 95th percentiles not given if n < 100; 10th and 90th percentiles not given if n < 75. Where n < 50, the mean and median should be interpreted with caution. Fifth and 95th percentiles not given if n < 100; 10th and 90th percentiles not given if n < 75. Where n < 50, the mean and median should be interpreted with caution. and 90th percentiles of the ratio of HDL-C to TC are plotted by age, sex, and hormone use in figures 1 to 3, and the means are compared by age, sex, and hormone use in figure 4. In these cross-sectional data there was apparent a consistent age-related decline in the percentage of TC carried by the HDL fraction in male participants (table 1, figure 1) from a mean of 36% in the age group 5 to 9 to a mean of 21. 1 % in the age group 50 to 54. Thereafter the percentage increased to a mean of 24.2% in the age group 60 to 64 and appeared to stabilize around this value.
In female participants not taking hormones (table 2, figure 2 ) the percentage of TC carried by HDL remained stable in the range of means from 32.4% to 33.4% for the age groups 5 to 9 to 30 to 34. Only in the age group 35 to 39 was there evidence of a decline from a mean of 32.6% to 30.0% and this value gradually declined to a mean of 25.8% in the age group 55 to 59. Thereafter there was a slight increase that appeared to stabilize around the value of 25% to 26%.
In women taking hormones (table 3, figure 3 ) the results were more difficult to interpret in view of the change from hormone use in the form of oral contraceptives (OC) to the use of replacement estrogen compounds. This changeover is likely to take place between the ages of 40 and 49 and as a result the values given for this age range include a mixed group of OC users and those taking replacement estrogens. (The results for this age range are shaded and indicated by a broken line in the graph in figures 3 and 4). Contrary to the pattern displayed by women not taking hormones, the decline in the percentage of TC carried by HDL was already evident in the age group 15 to 19, in which it constituted a mean of 33.0%, to the age group 20 to 24, in which it dropped to a mean of 30.6%. In women 30 to 39 years old, it appeared to stabilize around 30.0%, a value achieved by the nonhormone users only in the age range of 35 to 39.
As previously indicated, the perimenopausal age group of 40 to 49 includes both OC users and those on replacement estrogens. In the age range 50 to 69 the percentage of TC in HDL varied between 31 % and 33%; women on hormones in this age group had a mean value of 25%. The mean value of 29.7% for hormone users was computed with data from a small sample (38 women).
Distributions of the ratio of HDL-C to LDL-C are shown in tables 4 to 6. Although the ratio of HDL-C to LDL-C is considered to represent the ratio of the antiatherogenic to the atherogenic lipoprotein cholesterol fractions, the ratio of HDL-C to TC may be more useful in practice. HDL-C/TC is bounded since HDL-C is contained in the TC and the values of HDL-C/TC must lie between 0 and 1. On the other hand, HDL-C/LDL-C is not bounded, and thus the distribution of HDL-C/TC tends to be more symmetrical than that of HDL-C/LDL-C and is therefore a more convenient form for statistical analysis. Moreover, the results for the HDL-C/LDL-C ratio and its surrogate HDL-C/TC proportion parallel one another and they are essentially very similar. It should be noted, however, that the HDL-C/TC ratio is more likely to misrepresent the lipid profiles of individuals who are hypertriglyceridemic and have substantial amounts of VLDL-C. Tables 7 to 9 display the Pearson correlation coefficients between the various lipids and lipoproteins and selected lipoprotein ratios. Since little variation was observed in the magnitude of the correlation coefficients between different age groups, the tables list data from participants 5 years old and above combined. The HDL-C/TC ratio correlated highly with HDL-C/LDL-C (from .923 for men to .956 for women on hormones), suggesting that TC may serve as an adequate surrogate for LDL-C in the ratio of HDL-C/LDL-C.
Consequently, the ratio of HDL-C to TC is the one described in detail in this report. Since LDL-C is often approximated by the formula LDL-C* =TC -HDL-C -Triglycerides/5, the ratio of HDL-C/LDLUC* has been included in the correlation matrixes. As can be observed in tables 7 to 9, the correlations between Vol. 72 HDL-C to LDL-C for the black participants are presented by gender in tables 10 and 11. As indicated earlier, small sample sizes precluded the presentation of these data for black women reporting gonadal hormone use. Also, because of the smaller numbers of black examinees in the adult age range, wider age groupings have been used in tables 10 and 11. Similar to the trend observed for white males, black male participants showed a decline in the percentage of TC carried in HDL-C with age, from a mean of 38% at ages 5 to 9, to a mean of 24% in the decade 50 to 59 years. A slightly higher value of this ratio was observed in the group of examinees 60 and older. The last two values were calculated with data from small numbers of participants in each age stratum. It is of note that in every age group black male participants had a higher proportion of TC carried in HDL-C than white male participants. In black female participants not taking hormones the percentage of TC carried as HDL-C varied little by age between the ages 5 to 9 and 20 to 29. The magnitude of the HDL-C to TC ratio declined progressively in the older women. Whereas the age trend appeared to be similar in black and white women, the black women exhibited a higher percentage of TC in HDL-C than white women between ages 5 to 9 and 15 to 19. Thereafter, no appreciable differences in the magnitude of the ratio of HDL-C to TC could be 98 seen between black and white women of comparable age. As in the white study participants, the correlation between the ratios HDL-C/TC and HDL-C/LDL-C in black male and female participants was approximately .90.
Discussion
While the literature attests to increasing use of lipoprotein ratios of various forms to reflect the lipoprotein cholesterol contribution to an IHD risk profile, information on the behavior of these ratios in the general population is lacking. The purpose of this report is to provide a description of the distribution of a selected lipoprotein ratio viz HDL-C/TC by age, sex, and hormone use in a large population sample of residents of the U. S. and Canada. The choice of the ratio HDL-C/TC for detailed descriptive analyses was based on its relative ease of determination, computational simplicity, ease of interpretation and, perhaps most important, frequency of use in reports in the literature. Since HDL-C/TC is not just a ratio but actually a proportion, its range of values is bounded and its distribution is more symmetrical and thus more convenient for statistical analysis. It is also highly correlated with the ratio HDL-C/LDL-C and may possibly be regarded as a more conveniently determined surrogate for that ratio.
Previous descriptive studies of lipoprotein cholesterol levels in North American populations have generally been limited to the individual lipoproteins considered separately. However, there is now considerable epidemiologic and experimental evidence to suggest that both HDL-C and LDL-C levels are independently associated with the risk of IHD. Since both are lipid fractions that are postulated to participate in the atherogenic process via cholesterol transport and metabolism, it is intuitively appealing and appears scientifically sound to consider a single function to reflect the combined contribution of these lipoproteins to the risk of atherosclerotic disease.
In the pioneering work of Barr et al.,' both the mean HDL concentration and the mean percentage of HDL in the total blood lipoproteins were shown to differ in patients with and those without IHD. Brunner et al.i3 reported in 1962 that the percentage of TC carried by HDL was an index that effectively separated two ethnic groups, one with high and one with very low rates of IHD. By contrast, Sievers and Fisher24 and Howard et al. 25 observed that there was a lower ratio of HDL-C to LDL-C in Southwestern American Indians than in non-Indians, although the IHD incidence is considerably lower in the former than the latter.
In reporting on the role of HDL-C in IHD risk, Gordon et al.' of the Framingham Study found that the ratio of HDL-C to LDL-C or TC emerged as strong predictors of IHD in multiple logistic regression analysis. However, at the time they cautioned against the use of these ratios because of uncertain biological interpretation. Goldbourt and Medalie6 of the Israeli Ischemic Heart Disease Study described the distribution of the percentage of HDL-C in TC in their sample without commenting on the usefulness of this index.
Investigators from the Framingham Studies have advocated the use of the ratio of blood HDL-C to LDL-C or TC as the most convenient expression of their joint contribution to IHD risk.26 7 7 In the Framingham Offspring Study, Wilson et al.'7 found that the ratio of blood TC to HDL-C was strongly associated with IHD risk, but that its use in analysis was not superior to use of the two lipoprotein fractions separately. Recently Castelli et ali5 reported their findings in the evaluation of two specific ratios, namely TC/HDL-C and LDL-C/HDL-C. as predictors of CHD. Their main conclu- TABLE 8 Pearson correlation coefficients between selected lipids, lipoproteins, and lipoprotein ratios in white female participants not on hormones and 5 to 70+ years old (visit 2 random sample) HDL-C/ HDL-C! HDL-CI Abbreviations are as in table 7. sion was that these ratios were useful summary estimates of the information contained in the lipoprotein cholesterol fractions and were strong predictors of coronary heart disease. Either because lipoprotein ratios are regarded as a conceptually useful synthesis of a lipoprotein-cholesterol profile, or because of their potential use as an index of IHD risk, the literature reflects a rapidly growing use of these ratios. Ratios relating HDL-C to TC or LDL-C have been used to characterize dyslipoproteinemias,8-9myocardial infarction survivors and their relatives,33-3 angiographically defined coronary artery disease92, 363' and other morbid conditions such as hypertension,4 AI diabetes, 4 obesity ,4 and thyroid dysfunction. 49 Lipoprotein have also been reported with regard to gonadal hormone use,"' liver histology and disease,) drug therapy,J5 plasma exchange,-9 and jejunileal bypass."6 An association between lipoprotein ratio values and age has been addressed by several authors in diverse study designs and selected populations. 41 97 99 Various forms of lipoprotein ratios have been reported for populations TABLE 10 defined by geographic and ethnic criteria, such as Southwestern American Indian, 24 25 African,69 Israeli,6 Chinese,90 and Japanese,97 64 and Caucasian populations in various countries. Investigators have also described the association between certain risk factors of IHD and the lipoprotein cholesterol ratio, such as physical activity and smoking habits,'8 19 alcohol consumption,69 modified fat diets,66 vegetarian diets,67 and dietary fiber. 42 It is apparent from the literature that not only are lipoprotein ratios often used, but they are being used in a diversity of forms reflecting different choices of numerators and denominators. Recent publications have used the ratios HDL-C/TCA and TC/HDL-C.B HDL-C/LDL-C--5C 9 LDL-C/HDL-C HDL C/VLDL-C + LDL-C, -7976 and VLDL-C + LDL-C/HDL 9531 The ratio HDL-phospholipid/TC also has been used.39 This variety of formulations for the lipo-AReferences 28, 29,33-35. 39,40, 42 43, 45, 50, 51, 53,54, 58, 61, 63 65, 69, 70-72. BReferences 36, 37, 41. 46. 55. 56, 60, 66, 73. The distribution of the ratio of plasma HDL to TC and HDL to LDL-C (mg/dl) by protein ratios, as well as some heterogeneity in the rationale for their use, is indicative of the absence of common guidelines and conventions in the use of a measurement that researchers in a diversity of disciplines find appealing. One such deficiency is addressed in this study by the provision of population levels and distributional characteristics of a commonly used form of lipoprotein cholesterol ratio reflecting rigorous and standardized lipid laboratory measurements and well-defined samples of free-living populations.
While the lipoprotein ratios appear to be attractive measures of the joint contribution of the lipoprotein cholesterol fractions to IHD risk, several inconsistencies have not been resolved. At very low TC levels, it is possible that IHD risk may be low regardless of HDL-C levels. On the other hand, excessively high levels of TC may produce high risk of IHD even in the presence of elevated HDL-C levels. 77 The ratio of the lipoprotein fractions may not reflect this effect and may have little predictive power at the extremes of the blood TC distribution. Nonetheless, over the intermediate range of plasma TC concentrations the various ratios of the lipoprotein cholesterol fractions are frequently used as indexes of the lipid component of IHD risk, and in at least one large study, they have been found to be strongly predictive of IHD mortality.'
Certain qualifications are necessary for the interpretation of the analyses presented here. The descriptions of the distributions of selected lipoprotein cholesterol ratios in themselves do not address the issue of IHD risk. No attempt has been made (nor can be made on the basis of these data) to determine "optimal" or "abnormal" lipoprotein cholesterol ratios. Our analyses merely describe the distributions of the ratios in a broadly based sample of North Americans. It is hoped that this report will be useful as a reference guide for researchers and clinicians in evaluating their own populations.
The concept of a lipoprotein cholesterol ratio being somehow indicative of the atherogenic potential of the blood lipids may not be applicable to individuals with genetic disorders of lipid metabolism. The ratio distributions presented here are based on a population not selected on the basis of blood lipid levels, and only relatively few individuals with genetic lipid metabolism disorders are likely to have been included. Thus, the significance of lipoprotein cholesterol ratios in individuals with disorders such as familial dyslipoproteinemias may be quite different than that in a general population in which they may vary largely as a result of environmental factors.
Our results show that certain demographic and behavioral characteristics are of relevance in the evaluation of the HDL-C/TC index. The data presented in this report demonstrate profound effects of gonadal hormone use on the levels of the HDL-C/TC and HDL-C/LDL-C ratios. Of singular importance are the observed black-white differences in these ratios, e.g., the higher proportion of TC carried as HDL-C in the black compared with the white juveniles and adult men. These findings add to the evidence of racial differences in plasma lipid distributions4 29 and are noteworthy because of the limited population-based data available on non-Caucasians. Further, the age-related changes in the HDL-C/TC and HDL-C/LDL-C ratios observed for male and female participants are both somewhat different and more marked than those observed in the individual lipoproteins or in TC. This is a reflection of the combined effect of the changes in the individual lipoproteins. This observation has far-reaching implications if, as much epidemiologic and experimental evidence suggests, the risk of atherosclerotic disease depends on the combined, independent effects of HDL-C and LDL-C.
For white women using gonadal hormones, the mean HDL-C values increased substantially between the ages of 20 and 59. However, the mean HDL-C/TC ratio did not show any obvious change over that age range. These data should be interpreted with caution since the composition of the gonadal hormone used is not uniform over this age range; hormone use is likely to consist of both progestogen and estrogen in those under 40 and primarily of estrogen in the older group.
As a summary index of the lipid profile the HDL-C/TC proportion has considerable potential for simplifying a variety of functions in clinical practice and public health, such as risk assessment, screening, therapeutic decisions, and follow-up. Although not exhaustive regarding the information it conveys about a lipid pattern and concentration. the expression HDL-C/TC has the advantage of summarizing complex associations into a single numerical approximation. With the proviso that the absolute concentrations of the lipid measurements on which this index is based may contribute additional information by themselves, this summary index constitutes a meaningful statistic for individuals as well as for population groups. 
